Clinical Trials Directory

Trials / Completed

CompletedNCT04086277

Continuous Intrapartum Support to Reduce Primary Cesarean

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
IMSS Hospital General de Zona 4, Celaya, Guanajauto, Mexico · Other Government
Sex
Female
Age
14 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The objective of the study was to evaluate the intervention of intrapartum continuous support by a professional nurse with a university degree to reduce the nulliparous, term, singleton, vertex (NTSV) cesarean birth rate, in women pregnant less than 40 years in the HGZ No. 4 of the Guanajuato delegation of the Mexican Institute of Social Security, Mexico

Detailed description

Continuous intrapartum support is a strategy used to decrease the cesarean section rate, where multiple factors influence its effectiveness (start and duration of support, professional training of support staff, and others.). The objective of the study was to decrease the rate of deliveries by cesarean, through continuous intrapartum support during the active phase until birth, by a professional nurse with a university degree, the support was based on three basic aspects: 1) emotional support, 2) physical support and comfort measures and 3) information and counseling, for which a quasi-experimental study was conducted, with a study population of 115 women in labour (nulliparous, full-term, single product, vertex position) and under 40 years, a group control was formed (n = 55) who received routine maternal care and a study group (n = 60) who received continuous intrapartum support.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous Intrapartum SupportReceived the usual obstetric care plus continuous intrapartum support that was provided by a Bachelor of Nursing and Obstetrics who received prior training by a professional doula.

Timeline

Start date
2018-10-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2019-09-11
Last updated
2019-09-11

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04086277. Inclusion in this directory is not an endorsement.